Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
James Wynn’s $ETH Long Sees Partial Liquidation

James Wynn’s $ETH Long Sees Partial Liquidation

CoinomediaCoinomedia2025/08/20 07:00
By:Ava NakamuraAva Nakamura

James Wynn's $ETH long was partially liquidated, now holding 71.6 ETH with a liquidation price of $4,113.1.Risk Grows with Tight Liquidation RangeA Lesson for Leverage Traders

  • James Wynn’s Ethereum long position was partially liquidated.
  • He now holds 71.6 ETH worth approximately $300,000.
  • The new liquidation price is set at $4,113.1.

In just 10 hours, crypto trader James Wynn experienced a partial liquidation on his Ethereum ($ ETH ) long position. This move has adjusted his current holdings and risk levels in the market .

Despite the setback, Wynn still holds a sizable position—71.6 ETH, currently valued at around $300,000. However, the event has shifted his liquidation threshold to $4,113.1, adding pressure as ETH’s price continues to fluctuate in a volatile market environment.

Risk Grows with Tight Liquidation Range

A new liquidation price of $4,113.1 means Wynn’s position is now more vulnerable to sudden price drops. With crypto markets being highly sensitive to macroeconomic events, regulatory news, and whale movements, maintaining a large leveraged position can be a risky game.

If Ethereum dips closer to this level, Wynn risks losing more of his position unless he injects additional collateral or adjusts his leverage. His situation highlights the dangers of overexposure in leveraged trading, even for experienced traders.

A Lesson for Leverage Traders

Wynn’s liquidation shows how quickly things can turn in the crypto markets. Leveraged trading can amplify gains—but also magnify losses. Traders must remain vigilant, monitor price levels, and maintain healthy collateral ratios to avoid similar fates.

With ETH showing volatility, this case serves as a reminder: proper risk management is crucial, especially in a market that never sleeps.

Read also:

  • Fed’s Bowman Urges Staff to Hold Crypto for Insight
  • SkyBridge to Tokenize $300M in Assets on Avalanche
  • ETH Retests $4.1K: Key Resistance Now Turns to Support
  • Bitcoin and Ethereum ETFs See Over $900M in Outflows
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs Upgrades CoreWeave to "Buy": Market Overestimates Financing Costs and Underestimates Computing Fee Capabilities

Goldman Sachs has upgraded CoreWeave’s rating from “Neutral” to “Buy,” with a target price of $106, offering approximately 73% upside from the latest closing price of $61.39. Goldman Sachs believes the market is overly concerned about CoreWeave’s financing costs but underestimates its charging potential for computing power: asset-backed financing supported by GPU and customer contracts is not entirely tied to corporate bond yields. Additionally, annual revenue per megawatt is expected to rise from the current $10 million to $13 million, improving investment returns.

华尔街见闻•2026/10/19 13:01
Goldman Sachs Upgrades CoreWeave to "Buy": Market Overestimates Financing Costs and Underestimates Computing Fee Capabilities

AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market

CoreWeave's unsecured bonds have replaced Nvidia as the market's "beta barometer" for measuring AI trades. The bonds’ yields have surged past 16% and CDS spreads have soared, highlighting the high dependence of emerging cloud computing companies on debt financing and their funding gap risks. Credit pressures are spreading from infrastructure to equity markets, and the main focus of AI trading has shifted from computing power demand to financing costs and sustainability.

华尔街见闻•2026/10/19 12:46
AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market

GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.

智通财经•2026/10/19 11:37
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"

Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.

智通财经•2026/10/19 11:18